Greater than 90% of physicians using iKnowMed successfully attested to Meaningful Use in 2013 and earned more than $28 million in combined incentive payments since 2011
The Woodlands, Texas (May 31, 2014) — iKnowMedSM EHR (version 6.6.0), iKnowMed Generation 2 (version 2.0), and My Care PlusSM patient portal (version 3.0), oncology-specific products of McKesson Specialty Health, are all “Meaningful Use-ready” and have received 2014 Edition Complete EHR Certification. Combining the advanced technology of McKesson Specialty Health with expertise from physicians in The US Oncology Network, this oncology-specific suite of technology products provides unique support for clinicians and their patients.
Tested and certified under the Drummond Group's Electronic Health Records Office of the National Coordinator Authorized Certification Body (ONC-ACB) program, iKnowMed EHR, iKnowMed Generation 2 and My Care Plus are 2014 Edition compliant in accordance with the criteria adopted by the Secretary of Health and Human Services. Providers using certified EHR products can demonstrate Meaningful Use in 2014 and beyond and qualify for incentive payments while avoiding penalties under the American Recovery and Reinvestment Act (ARRA).
“Our 2014 Edition Meaningful Use certified products assist clinicians in providing the most advanced care to their patients through increased patient engagement, care coordination and clinical decision support,” said Jeffrey Kao, chief information officer, McKesson Specialty Health. “By incorporating the latest interoperability standards into our next generation healthcare technology products, we can improve information exchange with other electronic systems that have and need patient care details, including other EHR systems at collaborating practices and hospitals.”
Providing excellent Meaningful Use support for community-based oncology practices has been a top priority for the iKnowMed EHR team. In 2013, greater than 90 percent of physicians using iKnowMed successfully attested for Stage 1 Meaningful Use, earning them and their practices more than $28 million in combined incentive dollars since 2011. To help physicians and their staff meet Meaningful Use, McKesson Specialty Health offers staff support, project management tools and educational materials that assist users in navigating needed workflow changes. As providers enter Stages 1 or 2 of Meaningful Use in 2014, McKesson Specialty Health will continue to support their users in meeting the heightened requirements.
“I am pleased with the support the iKnowMed team provided to me and my practice. With their assistance, we were able to meet Stage 1 requirements quickly and efficiently as well as maximize the available incentives, benefiting the practice, but more importantly, our patients,” said Yoosaf Abraham (Abe), chief operating officer, Cancer Center of Kansas. “With the team’s support, I know we will be able to meet Stage 2 requirements and implement new technologies to benefit patients, including a patient portal that will improve our ability to engage with patients online.”
To support users with heightened Stage 1 and 2 requirements that require providers to engage patients digitally, iKnowMed EHR and iKnowMed Generation 2 users leverage the My Care Plus patient portal, which currently provides more than 75,000 enrolled patients with secure, online access to their health records. The patient portal gives patients the ability to easily share information with their providers, caregivers and family members; plus, view lab results, send secure messages to their providers and access educational resources specific to their condition and treatment.
iKnowMed and iKnowMed Generation 2 were developed in collaboration with oncologists to meet the unique needs of cancer patients and have been implemented in more than 550 sites of care nationwide and used by 1,400 providers. iKnowMed Generation 2 builds upon the robust, oncology-specific electronic health record features of iKnowMed, which was named the top ranked EHR for oncologists and hematologists by Black Book Rankings for three consecutive years.
iKnowMed EHR version 6.6.0 was certified on May 30, 2014. Certification ID number 05302014‐2325‐8. Modules tested and certified: 170.314(a)(1‐15); 170.314(b)(1‐5, 7); 170.314(c)(1‐3); 170.314(d)(1‐8); 170.314(e)(1‐3); 170.314(f)(1‐3, 5); 170.314(g)(2‐4). Clinical Quality Measures tested and certified: CMS002v3; CMS068v3; CMS069v2; CMS126v2; CMS138v2; CMS147v2; CMS156v2; CMS157v2; CMS165v2. Additional software relied upon to certify: Surescripts Clinical Interoperability.
iKnowMed Generation 2 version 2.0 was certified on May 30, 2014. Certification ID number 05302014‐2326‐8. Modules tested and certified: 170.314(a)(1‐15); 170.314(b)(1‐5, 7); 170.314(c)(1‐3);
170.314(d)(1‐8); 170.314(e)(1‐3); 170.314(f)(1‐3, 5); 170.314(g)(2‐4). Clinical Quality Measures tested and certified: CMS002v3; CMS068v3; CMS069v2; CMS126v2; CMS138v2; CMS147v2; CMS156v2; CMS157v2; CMS165v2. Additional software relied upon to certify: NewCropRx, Surescripts Clinical Interoperability.
These Complete EHRs are 2014 Edition compliant and have been certified by an ONC‐ACB in accordance with the applicable certification criteria adopted by the Secretary of the U.S. Department of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments.
McKesson Specialty Health EHR and patient portal software services require a one-time implementation fee for installation plus monthly subscription fees which cover software licenses, customer support, software upgrades, and services required to meet Meaningful Use objectives and measures. Interfaces or health information exchange integration require additional implementation fees and monthly subscription fees.
Learn more about iKnowMed Generation 2 and My Care Plus by visiting www.McKessonspecialtyhealth.com/iKnowMed.
About McKesson Specialty Health
McKesson Specialty Health, a division of McKesson Corporation, empowers the community patient care delivery system by helping community practices advance the science, technology and quality of care. Through innovative clinical, research, business and operational solutions, facilitated by integrated technology systems, we focus on improving the financial health of our customers so they may provide the best care to their patients. For more information, visit www.McKessonspecialtyhealth.com.
About The US Oncology Network
The US Oncology Network is one of the nation’s largest networks of integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. A physician-led organization, The US Oncology Network unites like-minded physicians and clinicians around a common vision of improving patient outcomes and quality of life. Leveraging healthcare information technology, shared best practices, evidence-based guidelines and quality measurements, physicians within The US Oncology Network are pioneering new ways to achieve this vision. The US Oncology Network is committed to strengthening patient access to integrated care in local communities across the nation, including collaboration with a variety of payers, hospitals and academic institutions. The US Oncology Network is supported by McKesson Specialty Health, a division of McKesson Corporation focused on empowering a vibrant and sustainable community patient care delivery system. For more information, visit www.usoncology.com.
About Drummond Group Inc.
Drummond Group Inc. is a global software test and certification lab that serves a wide range of vertical industries. In healthcare, Drummond Group tests and certifies Controlled Substance Ordering Systems (CSOS), Electronic Prescription of Controlled Substances (EPCS) software and processes, and Electronic Health Records (EHRs) – designating the trusted test lab as the only third-party certifier of all three initiatives designed to move the industry toward a digital future. Founded in 1999, and accredited for the Office of the National Coordinator HIT Certification Program as an Authorized Certification Body (ACB) and an Accredited Test Lab (ATL), Drummond Group continues to build upon its deep experience and expertise necessary to deliver reliable and cost-effective services. For more information, please visit http://www.drummondgroup.com or email DGI@drummondgroup.com.